Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$20.03 - $40.08 $984,053 - $1.97 Million
-49,129 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$19.89 - $30.02 $276,868 - $417,878
-13,920 Reduced 22.08%
49,129 $1.24 Million
Q3 2018

Nov 08, 2018

SELL
$12.1 - $28.85 $453,895 - $1.08 Million
-37,512 Reduced 37.3%
63,049 $1.82 Million
Q2 2018

Aug 03, 2018

SELL
$7.93 - $15.79 $406,999 - $810,405
-51,324 Reduced 33.79%
100,561 $1.23 Million
Q1 2018

Jun 04, 2018

BUY
$5.18 - $7.97 $13,530 - $20,817
2,612 Added 1.75%
151,885 $1.21 Million
Q4 2017

Jun 04, 2018

BUY
$3.98 - $7.37 $594,106 - $1.1 Million
149,273
149,273 $1.1 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.